Sign in
Enrolling by invitationNo phase

Using breath tests to spot gestational diabetes early in high-risk women

Studies breath markers to predict gestational diabetes in women at high risk.

Key facts

Who runs it
Tianjin Central Hospital of Gynecology Obstetrics
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics
Status
Enrolling by invitation
People taking part
600 people, planned
Started
25 Dec 2024
Expected to end
Dec 2027
Type of study
Observational, 2 groups
Record updated
31 May 2025

Who can take part

The trial is looking for pregnant women at 11-14 weeks with at least one risk factor for gestational diabetes. It studies breath tests to predict diabetes in pregnancy early.

Age
18-55 years old
Sex
Women only
Disease stage
11-14 weeks of pregnancy, with at least one risk factor for gestational diabetes (GDM).
Main reasons for not taking part
  • Diabetes or abnormal blood sugar before pregnancy
  • Severe vomiting in pregnancy (hyperemesis gravidarum) with ketones in the urine
  • Thyroid problems, asthma, lung disease or high blood pressure that is hard to control
  • Cancer, severe liver or kidney failure, or acute inflammation
  • Smokers, or people with nose, throat or mouth problems that prevent giving breath samples

This trial only enrols pregnant participants. The registry sentence this rests on: * 11-14 weeks of pregnancy

Show the full registry criteria (17)Hide the full registry criteria

Who cannot take part

  • Hypertensive diseases that are difficult to control
  • Severe hepatic and renal insufficiency or severe electrolyte disturbance
  • Malignant tumor
  • lung disease
  • Patients with gastritis, duodenum and other digestive system diseases
  • Diabetes mellitus or abnormal glucose metabolism before pregnancy
  • Hyperemesis gravidarum (urine ketone positive))
  • Thyroid dysfunction
  • Asthmatic patients
  • Acute inflammation
  • Those with upper respiratory or oral problems who cannot cooperate with expiratory collection
  • smoker

Other criteria

  • Eligibility Criteria
  • 18-55 years old
  • 11-14 weeks of pregnancy
  • at least one risk factor for GDM
  • signed a written informed consent

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sex
  • Gestational diabetes

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aim to develope novel breath markers of gestational diabetes through a prospective high-risk population cohort study and achieve early prediction of gestational diabetes based on an interpretable machine learning model.

The 2 groups in the trial

  • Gestational Diabetes Group
  • control group

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Cohort Study in Women at High Risk for Gestational Diabetes Based on Breath Metabolomics
Plain-language title
Using breath tests to spot gestational diabetes early in high-risk womenGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06753734, who can take part
Record updated
31 May 2025